4//SEC Filing
Nolan Garry Ph.D. 4
Accession 0001104659-21-072003
CIK 0001711933other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 9:53 PM ET
Size
6.1 KB
Accession
0001104659-21-072003
Insider Transaction Report
Form 4
Nolan Garry Ph.D.
Director
Transactions
- Award
Stock Option (Right to Buy
2021-05-21+16,860→ 16,860 totalExercise: $21.95Exp: 2031-05-21→ Common Stock (16,860 underlying)
Holdings
- 680,084
Common Stock
Footnotes (1)
- [F1]Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) May 21, 2022, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant.
Documents
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001857405
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 9:53 PM ET
- Size
- 6.1 KB